Breaking News Instant updates and real-time market news.

PCRX

Pacira

$35.65

-1.05 (-2.86%)

, HRTX

Heron Therapeutics

$29.40

0.3 (1.03%)

15:01
04/12/18
04/12
15:01
04/12/18
15:01

Draft bill could be good for Heron, seems to exclude Pacira drug, says Cowen

Cowen analyst Boris Peaker said a draft bill creating a pass-through payment for non-opioid analgesics as part of surgical procedures appears to exclude Pacira's (PCRX) Exparel, but could benefit Heron Therapeutics' (HRTX) HTX-011. He also noted, though, that several bills would promote the use of local anesthetics. The House E&C committee is planning to move into more formal legislative drafting mode with the goal of reporting legislation out before Memorial Day, Peaker added.

PCRX

Pacira

$35.65

-1.05 (-2.86%)

HRTX

Heron Therapeutics

$29.40

0.3 (1.03%)

  • 16

    Apr

  • 17

    Apr

  • 18

    Apr

  • 25

    Apr

  • 27

    Apr

  • 08

    May

PCRX Pacira
$35.65

-1.05 (-2.86%)

04/10/18
MZHO
04/10/18
NO CHANGE
Target $35
MZHO
Buy
Pacira label changes positive for Heron, says Mizuho
Mizuho analyst Difei Yang views FDA approval of Pacira Pharmaceuticals (PCRX) Exparel in nerve block as positive for Heron Therapeutics' (HRTX) HTX-011. The FDA updated the label information of Exparel to include detail on the opioid sparing properties of the drug, which appear "modest and potentially not clinically meaningful," Yang tells investors in a research note. This is in contrast to HTX-011, which has demonstrated "superior opioid sparing properties" in a number of studies including the latest Phase 3 trials, the analyst contends. Yang keeps a Buy rating on Heron with a $35 price target.
04/09/18
BMOC
04/09/18
NO CHANGE
Target $34
BMOC
Market Perform
Pacira price target raised to $34 at BMO Capital after Exparel approval
BMO Capital analyst Gary Nachman raised his price target on Pacira to $34 from $31, citing Friday's announcement of FDA approval of an upper extremity nerve block indication for Exparel on the PDUFA. Nachman says this was a "surprising outcome" given a negative panel decision in February, but adds that the indication is also narrow in that it is "limited to an intrascalene brachial plexus block". The analyst keeps his Market Perform rating on Pacira, stating that while Exparel is a " solid product for post-surgical pain, further penetration is challenging and consensus expectations remain high".
04/09/18
HCWC
04/09/18
NO CHANGE
Target $48
HCWC
Buy
Pacira price target raised to $48 from $45 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat raised his price target for Pacira Pharmaceuticals to $48 after the FDA approved an additional "narrow" nerve block indication for Exparel. The FDA added a specific interscalene brachial plexus block indication for regional anesthesia, effectively an indication for shoulder replacement or rotator cuff repair, Livnat tells investors in a research note. While a broad general nerve block indication would have been best case, and Pacira has to be careful not to promote off-label, this is still an "important positive," the analyst contends. He reiterates a Buy rating on Pacira shares.
04/09/18
JPMS
04/09/18
NO CHANGE
JPMS
Neutral
Pacira nerve block approval a 'clear positive,' at JPMorgan
In a research note partially titled "Something's Better Than Nothing," JPMorgan analyst Chris Schott says Friday night's FDA approval for nerve block is a "clear positive" for Pacira Pharmaceuticals. He notes that the Street broadly expected a Complete Response Letter for Exparel in this indication. While the approval does not include a broad nerve block label, it does allow Pacira to target 1M shoulder blocks performed annually, Schott tells investors. However, the Exparel label update also included several failed nerve block studies that should limit off label use of the drug, the analyst adds. He keeps a Neutral rating on Pacira.
HRTX Heron Therapeutics
$29.40

0.3 (1.03%)

04/09/18
PIPR
04/09/18
NO CHANGE
Target $44
PIPR
Overweight
Piper reiterates Overweight on Pacira after 'watershed' nerve block approval
FDA approval of Pacira Pharmaceuticals' (PCRX) Exparel as a brachial plexus block "is something of a watershed" in that the agency has never before approved any local or regional anesthetic for a single, specific setting, Piper Jaffray analyst David Amsellem tells investors in a research note. He believes the approval suggests an increasingly aggressive FDA approach towards the opioid crisis. Amsellem points out, however, that feedback from his surgeon survey suggests a "strong degree of enthusiasm" for Heron Therapeutics' (HTRX) HTX-011. However, the feedback also indicates that non-opioid, post-operative pain space is not a zero-sum game, the analyst writes. He believes Exparel can grow "even amid greater competition." Amsellem reiterates an Overweight rating on Pacira with a $44 price target.
04/05/18
EVER
04/05/18
INITIATION
Target $56
EVER
Outperform
Heron Therapeutics initiated with an Outperform at Evercore ISI
Evercore ISI analyst Joshua Schimmer started Heron Therapeutics (HRTX) with an Outperform rating and $56 price target. He said that given the marked differentiation versus Pacira's (PCRX) Exparel, peak sales for Heron's HTX-011 could approach $2.5B, while Sustol/Cinvanti could add another $300M at peak. These estimates could drive a valuation potentially approaching $11B, or nearly $175 per share, in a bullish scenario, said Schimmer.
04/05/18
LSCM
04/05/18
NO CHANGE
Target $42
LSCM
Buy
Heron 'ready for liftoff' after secondary offering, says Lake Street
Lake Street analyst Bruce Jackson updated his model for Heron Therapeutics following the recently completed stock offering. In a research note partially titled, "Fuel Tank Filled, Ready For Lift Off," the analyst reiterates a Buy rating on Heron with a $42 price target. New Phase 3 data for HTX-011 demonstrated statistically significant reductions in pain intensity and opioid use through 72 hours post-surgery compared to placebo and the current standard of care, bupivacaine, Jackson writes. He notes that management believes the data support an opioid-sparing labeling claim for HTX-011. This would provide a significant competitive advantage, the analyst contends.

TODAY'S FREE FLY STORIES

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

18:08
04/20/18
04/20
18:08
04/20/18
18:08
Periodicals
North Korea to suspend nuclear and ICBM tests, Bloomberg reports »

North Korea also plans to…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

, BG

Bunge

$73.72

-1.935 (-2.56%)

18:03
04/20/18
04/20
18:03
04/20/18
18:03
Periodicals
Archer Daniels, Bunge talks end without merger deal, Bloomberg reports »

Advanced merger…

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

BG

Bunge

$73.72

-1.935 (-2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

CE

Celanese

$111.69

0.56 (0.50%)

18:02
04/20/18
04/20
18:02
04/20/18
18:02
Hot Stocks
Celanese announces price increases in Asia »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

IOTS

Adesto Technologies

$8.65

-0.2 (-2.26%)

17:33
04/20/18
04/20
17:33
04/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Adesto Technologies »

180 Degree Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SIGM

Sigma Designs

$6.30

0.1 (1.61%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Sigma Designs to delay filing Annual Report on Form 10-K »

Sigma Designs is unable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

, BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Breaking Hot Stocks news story on Berkshire Hathaway, Berkshire Hathaway, Torchmark »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

TMK

Torchmark

$87.22

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

, CG

Carlyle Group

$20.85

0.15 (0.72%)

17:17
04/20/18
04/20
17:17
04/20/18
17:17
Syndicate
SEACOR Marine Holdings announces $56.9M private placement of common stock »

SEACOR Marine Holdings…

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

CG

Carlyle Group

$20.85

0.15 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AVAV

AeroVironment

$56.66

-0.15 (-0.26%)

17:12
04/20/18
04/20
17:12
04/20/18
17:12
Hot Stocks
AeroVironment awarded $44.7M U.S. Army contract modification »

AeroVironment was awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

, XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

17:10
04/20/18
04/20
17:10
04/20/18
17:10
General news
Week ending ETF Scorecard: Energy outperforms again, Staples lag »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

IYR

DJ US Real Estate Index Fund

$73.94

-0.62 (-0.83%)

XLP

Consumer Staples Sector SPDR

$50.49

-0.85 (-1.66%)

XLY

Consumer Discretionary Sector SPDR

$102.97

-1.06 (-1.02%)

XLB

S&P Select Materials SPDR

$59.00

-0.36 (-0.61%)

XLF

Financial Select Sector

$27.89

0.015 (0.05%)

XLV

Health Care Select Sector SPDR

$82.10

-0.45 (-0.55%)

XLK

Technology Select Sector SPDR

$66.18

-0.97 (-1.44%)

XLI

Industrial Select Sector SPDR

$75.59

-0.32 (-0.42%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

SLV

iShares Silver Trust

$16.14

-0.11 (-0.68%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

UNG

United States Natural Gas Fund

$22.56

0.475 (2.15%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.91

-0.19 (-0.22%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.47

-0.49 (-0.42%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

-0.88 (-0.74%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.57

-0.355 (-0.35%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.03 (-0.04%)

IWD

iShares Russell 1000 Value

$121.38

-0.61 (-0.50%)

IWF

iShares Russell 1000 Growth

$137.65

-1.53 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.16

-0.0051 (-3.02%)

17:07
04/20/18
04/20
17:07
04/20/18
17:07
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$86.98

-0.9 (-1.02%)

, FB

Facebook

$166.29

-1.82 (-1.08%)

17:05
04/20/18
04/20
17:05
04/20/18
17:05
Hot Stocks
Walmart says Kevin Systrom will not stand for re-election to board »

Walmart and Systrom, the…

WMT

Walmart

$86.98

-0.9 (-1.02%)

FB

Facebook

$166.29

-1.82 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 25

    Apr

  • 17

    May

  • 30

    May

  • 01

    Jun

WMT

Walmart

$86.98

-0.9 (-1.02%)

, MCD

McDonald's

$158.77

-0.76 (-0.48%)

17:03
04/20/18
04/20
17:03
04/20/18
17:03
Hot Stocks
Walmart announces McDonald's Steve Easterbrook as independent nominee to board »

"This year's…

WMT

Walmart

$86.98

-0.9 (-1.02%)

MCD

McDonald's

$158.77

-0.76 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 30

    Apr

  • 17

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

, USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

17:00
04/20/18
04/20
17:00
04/20/18
17:00
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.5K…

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

FXE

Euro Currency Trust

$118.04

-0.65 (-0.55%)

FXC

CurrencyShares Canadian Dollar Trust

$77.37

-0.54 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.86

0.01 (0.35%)

16:59
04/20/18
04/20
16:59
04/20/18
16:59
Syndicate
Breaking Syndicate news story on Citius Pharmaceuticals »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
04/20/18
04/20
16:55
04/20/18
16:55
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

FPI

Farmland Partners

$7.85

-0.24 (-2.97%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Syndicate
Breaking Syndicate news story on Farmland Partners »

Farmland Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$8.85

0.05 (0.57%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

PVAM Perlus Microcap Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:46
04/20/18
04/20
16:46
04/20/18
16:46
Syndicate
American Midstream Partners files $150M preferred unit offering »

The offering is for $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:41
04/20/18
04/20
16:41
04/20/18
16:41
Syndicate
American Midstream Partners requests withdrawal of registration statement »

The Partnership has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSC

Seven Stars Cloud Group

$2.67

-0.1 (-3.61%)

16:40
04/20/18
04/20
16:40
04/20/18
16:40
Syndicate
Breaking Syndicate news story on Seven Stars Cloud Group »

Seven Stars Cloud Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:39
04/20/18
04/20
16:39
04/20/18
16:39
Hot Stocks
HNI Corporation CEO says 'seeing increased inflationary pressures' »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:38
04/20/18
04/20
16:38
04/20/18
16:38
Earnings
HNI Corporation narrows FY18 adjusted EPS view to $2.40-$2.70 from $2.40-$2.80 »

FY18 consensus $2.54. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:35
04/20/18
04/20
16:35
04/20/18
16:35
Earnings
HNI Corporation sees Q2 adjusted EPS 28c-38c ex-costs, consensus 56c »

Sees Q2 organic revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

WHR

Whirlpool

$149.43

-2.505 (-1.65%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Whirlpool »

Whirlpool files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GEL

Genesis Energy

$21.24

0.065 (0.31%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Genesis Energy »

Genesis Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.